Darcy Spicer

5.8k total citations · 1 hit paper
91 papers, 3.8k citations indexed

About

Darcy Spicer is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Darcy Spicer has authored 91 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 18 papers in Cancer Research and 17 papers in Genetics. Recurrent topics in Darcy Spicer's work include Cancer Risks and Factors (16 papers), Estrogen and related hormone effects (13 papers) and Breast Cancer Treatment Studies (13 papers). Darcy Spicer is often cited by papers focused on Cancer Risks and Factors (16 papers), Estrogen and related hormone effects (13 papers) and Breast Cancer Treatment Studies (13 papers). Darcy Spicer collaborates with scholars based in United States, Canada and Norway. Darcy Spicer's co-authors include Malcolm C. Pike, Michael F. Press, Laila Dahmoush, Leslie Bernstein, Giske Ursin, Susan Groshen, Christina M. Dieli‐Conwright, Nathalie Sami, Kyuwan Lee and Eunjung Lee and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Darcy Spicer

91 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk

1993 815 citations Malcolm C. Pike, Darcy Spicer et al. profile →

Peers

Countries citing papers authored by Darcy Spicer

Since Specialization

Citations

This map shows the geographic impact of Darcy Spicer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darcy Spicer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darcy Spicer more than expected).

Fields of papers citing papers by Darcy Spicer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darcy Spicer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darcy Spicer. The network helps show where Darcy Spicer may publish in the future.

Co-authorship network of co-authors of Darcy Spicer

This figure shows the co-authorship network connecting the top 25 collaborators of Darcy Spicer. A scholar is included among the top collaborators of Darcy Spicer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darcy Spicer. Darcy Spicer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions 2023 ·Oncogene ·Priya Jayachandran, Francesca Battaglin, (unknown), Annika Lenz, (unknown), Shivani Soni, Jae Ho Lo, (unknown), Joshua Millstein, Wu Zhang, Jean C. Shih, Janice Lu, Shannon M. Mumenthaler, Darcy Spicer, Josh Neman, Evanthia T. Roussos Torres, Heinz‐Josef Lenz	17
2	Experiences of a Multiethnic Cohort of Patients Enrolled in a Financial Reimbursement Program for Cancer Clinical Trials 2023 ·JCO Oncology Practice ·(unknown), (unknown), (unknown), (unknown), Robert G. Johnson, Darcy Spicer, Hala T. Borno	7
3	Implementation of a Multisite Financial Reimbursement Program in Cancer Clinical Trials Integrated With Patient Navigation: A Pilot Randomized Clinical Trial 2022 ·JCO Oncology Practice ·Hala T. Borno, Li Zhang, (unknown), Tracy Kuo Lin, (unknown), (unknown), (unknown), Robert G. Johnson, Kim F. Rhoads, Eric J. Small, Darcy Spicer	11
4	Disease characterization in liquid biopsy from HER2-mutated, non-amplified metastatic breast cancer patients treated with neratinib 2022 ·npj Breast Cancer ·Stephanie N. Shishido, (unknown), Liya Xu, Lisa Welter, Rishvanth K. Prabakar, (unknown), Darcy Spicer, Irene Kang, Priya Jayachandran, James Hicks, Janice Lu, Peter Kühn	17
5	Aerobic and resistance exercise improve patient-reported sleep quality and is associated with cardiometabolic biomarkers in Hispanic and non-Hispanic breast cancer survivors who are overweight or obese: results from a secondary analysis 2021 ·SLEEP ·Christina M. Dieli‐Conwright, Kerry S. Courneya, Wendy Demark‐Wahnefried, Nathalie Sami, Mary K. Norris, Frank Fox, Thomas A. Buchanan, Darcy Spicer, Leslie Bernstein, Debu Tripathy	21
6	Accelerating cancer clinical trial recruitment through a financial reimbursement program integrated with patient navigation: an interrupted time series analysis 2021 ·Journal of Cancer Policy ·Hala T. Borno, Tracy Kuo Lin, (unknown), (unknown), (unknown), (unknown), Robert G. Johnson, Darcy Spicer, Eric J. Small, Kim F. Rhoads	15
7	Broad inclusion leads to maximal value – examining travel costs associated with clinical trial participation 2021 ·Hala T. Borno, (unknown), (unknown), (unknown), Robert G. Johnson, Darcy Spicer, Tracy Kuo Lin	1
8	Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study 2020 ·Breast Cancer Research and Treatment ·Anna H. Wu, Chiu-Chen Tseng, Cheryl Vigen, Yang Yu, Wendy Cozen, Agustin A. García, Darcy Spicer	77
9	Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial 2018 ·Journal of Clinical Oncology ·Christina M. Dieli‐Conwright, Kerry S. Courneya, Wendy Demark‐Wahnefried, Nathalie Sami, Kyuwan Lee, Thomas A. Buchanan, Darcy Spicer, Debu Tripathy, Leslie Bernstein, Joanne Mortimer	271
10	Hispanic ethnicity as a moderator of the effects of aerobic and resistance exercise in survivors of breast cancer 2018 ·Cancer ·Christina M. Dieli‐Conwright, Frank C. Sweeney, Kerry S. Courneya, Debu Tripathy, Nathalie Sami, Kyuwan Lee, Thomas A. Buchanan, Darcy Spicer, Leslie Bernstein, Joanne Mortimer, Wendy Demark‐Wahnefried	18
11	Efficacy of Very-Low-Dose Capecitabine in Metastatic Breast Cancer 2015 ·(unknown), Lingyun Ji, Agustin A. García, Christy Russell, Darcy Spicer, Richard Sposto, Debu Tripathy	2
12	Characteristics of Triple-Negative Breast Cancer in Patients With a BRCA1 Mutation: Results From a Population-Based Study of Young Women 2011 ·Journal of Clinical Oncology ·Eunjung Lee, Roberta McKean‐Cowdin, Huiyan Ma, Darcy Spicer, David Van Den Berg, Leslie Bernstein, Giske Ursin	93
13	Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival 2010 ·Breast Cancer Research and Treatment ·Sylvia Adams, A. Bapsi Chakravarthy, Martin Donach, Darcy Spicer, Stella Lymberis, Baljit Singh, Joshua A. Bauer, Tsivia Hochman, Judith D. Goldberg, Franco M. Muggia, Robert J. Schneider, Jennifer A. Pietenpol, Silvia C. Formenti	63
14	GRP78 as a Novel Predictor of Responsiveness to Chemotherapy in Breast Cancer 2006 ·Cancer Research ·Eunjung Lee, Peter W. Nichols, Darcy Spicer, Susan Groshen, Mimi C. Yu, Amy S. Lee	240
15	Low HER2/neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer 2002 ·International Journal of Radiation OncologyBiologyPhysics ·Silvia C. Formenti, Darcy Spicer, Kristin A. Skinner, (unknown), Susan Groshen, Anna Bettini, Wesley Y. Naritoku, Michael F. Press, Dennis Salonga, Denice Tsao‐Wei, K. D. Danenberg, Peter V. Danenberg	32
16	Hormonal contraception and chemoprevention of female cancers. 2000 ·Endocrine Related Cancer ·Malcolm C. Pike, Darcy Spicer	42
17	Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation 2000 ·Cancer Chemotherapy and Pharmacology ·John D. Roberts, Elizabeth Poplin, Mary Beth Tombes, (unknown), Darcy Spicer, Steven Grant, Timothy W. Synold, Richard G. Moran	26
18	Original p53 status predicts for pathological response in locally advanced breast cancer patients treated preoperatively with continuous infusion 5-Fluorouracil and radiation therapy 1997 ·International Journal of Radiation OncologyBiologyPhysics ·Silvia C. Formenti, Gary L. Dunnington, (unknown), Heinz Josef Lenz, (unknown), Howard Silberman, Darcy Spicer, (unknown), (unknown), Susan Groshen, Kristy Watkins, Franco M. Muggia, Barbara D. Florentine, Michael F. Press, Kathleen D. Danenberg, Peter V. Danenberg	47
19	Breast cancer prevention through modulation of endogenous hormones 1993 ·Breast Cancer Research and Treatment ·Darcy Spicer, M C Pike	17
20	Reevaluation of the maximum tolerated dose of continuous venous infusion of 5-fluorouracil with pharmacokinetics. 1988 ·PubMed ·Darcy Spicer, Bach Ardalan, John R. Daniels, Howard Silberman, Kay Johnson	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact